<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-22-01290-t001" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">molecules-22-01290-t001_Table 1</object-id>
 <label class="label">Table 1</label>
 <caption class="caption">
  <p class="p">Aromatic plant essential oils studied in experimental depression.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Essential Oils</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Administration via and Duration of Treatment</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Animal Specie</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Dose Range Tested and Minimal Active Dose</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Behavioral Test</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Observed Effects</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Observations</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Reference</th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Acorus tatarinowii</italic> Schott
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">30–240 mg/kg 
     <break class="break"/>(60 mg/kg)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both assays</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B33-molecules-22-01290" ref-type="bibr" class="xref">33</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">U-inverted curve</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Asarum heterotropoides</italic> F. Schmidt
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">0.25–2.0 g 
     <break class="break"/>(0.25 g)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both tests</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reversed the increase of CRF- and TH-positive cells in the paraventricular nucleus, and locus coeruleus, respectively;</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">DR+
     <break class="break"/>Controls: negative and positive (fluoxetine)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B34-molecules-22-01290" ref-type="bibr" class="xref">34</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reversed the decrease of 5-HT-positive cells in the dorsal raphe nucleus</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Citrus limon</italic> (L.) Osbeck
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(90 min)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The treatment with flumazenil (GABA
     <sub class="sub">A</sub> antagonist), buspirone (5-HT
     <sub class="sub">1A</sub> partial agonist), DOI (5-HT
     <sub class="sub">2A</sub> receptor agonist), miaserin (5-HT
     <sub class="sub">2A/C</sub> receptor agonist), apomorphin (D receptor agonist) and haloperidol (D receptor antagonist) blocked the antidepressant effect. Increased hippocampal DA and prefrontal cortex and hippocampal 5-HT
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B35-molecules-22-01290" ref-type="bibr" class="xref">35</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced spontaneous locomotor activity</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Citrus limon</italic> (L.) Osbeck
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rats</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(60 min)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B36-molecules-22-01290" ref-type="bibr" class="xref">36</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced spontaneous locomotor activity</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Citrus limon</italic> (L.) Osbeck
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 30 days</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">50–150 mg/kg 
     <break class="break"/>(50 mg/kg)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B37-molecules-22-01290" ref-type="bibr" class="xref">37</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine and paroxetine)</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The treatment decreased spontaneous locomotion increased sleeping duration</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Eugenia uniflora</italic> L.
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">1–50 mg/kg 
     <break class="break"/>(10 mg/kg)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">TST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The blockade of 5-HT2
     <sub class="sub">A/C</sub>, α
     <sub class="sub">1</sub> and α
     <sub class="sub">2</sub>-receptors prevented the antidepressant effects;
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">DR+
     <break class="break"/>Controls: negative and positive (fluoxetine)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B38-molecules-22-01290" ref-type="bibr" class="xref">38</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">In vitro inhibition of linoleic acid peroxidation;</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced SNP-induced lipoperoxidation in cortex, hippocampus and cerebellum</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Lavandula angustifólia</italic> Mill.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">5–20% (5%)</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B39-molecules-22-01290" ref-type="bibr" class="xref">39</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Lavandula angustifólia</italic> Mill.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(90 min)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No effects were observed</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B35-molecules-22-01290" ref-type="bibr" class="xref">35</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Litsea glaucescens</italic> Kunth
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">54.8–300 mg/kg 
     <break class="break"/>(100 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Mentha</italic> × 
     <italic class="italic">piperita</italic> L.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse (female)</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(10 min)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B41-molecules-22-01290" ref-type="bibr" class="xref">41</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Perilla frutescens</italic> L. Britton
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 3 weeks</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">3–9 mg/kg 
     <break class="break"/>(3 mg/kg)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, FST, TST, OFT</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Restored sucrose preference in CUMS mice;</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the 5-HT and 5-HIAA reduced concentrations in CUMS mice; 
     <break class="break"/>Restored the serum IL-6, IL-1β, and TNF-α levels in CUMS mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B42-molecules-22-01290" ref-type="bibr" class="xref">42</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reverted the reduced spontaneous locomotion in CUMS mice;</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">U-inverted curve</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Restored increased immobility time in CUMS mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Perilla frutescens</italic> L. Britton
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 3 and 4 weeks</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">3–6 mg/kg 
     <break class="break"/>(3 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, FST, sucrose preference</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored the CUMS-induced decreased sucrose preference and increased immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored the CUMS-induced reduction of hippocampal protein and mRNA BDNF</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B43-molecules-22-01290" ref-type="bibr" class="xref">43</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Rosmarinus officinalis</italic> L.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">0.1–100 mg/kg 
     <break class="break"/>(0.1 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">TST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B44-molecules-22-01290" ref-type="bibr" class="xref">44</xref>,
     <xref rid="B45-molecules-22-01290" ref-type="bibr" class="xref">45</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Rosmarinus officinalis</italic> L.
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">5–20% 
     <break class="break"/>(5%)
    </td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B39-molecules-22-01290" ref-type="bibr" class="xref">39</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">U-inverted curve</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Salvia sclarea</italic> L.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal and inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">5–20% (5%); satured chamber 
     <break class="break"/>(1, 2, 4 and 6 h)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time when injected and inhaled</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The pretreatment with haloperidol (Dopamine receptor antagonist), SCH-23390 (D1 receptor antagonist) and buspirone (5-HT
     <sub class="sub">1A</sub> partial agonist) blocked the antidepressant effect
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B39-molecules-22-01290" ref-type="bibr" class="xref">39</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Schinus terebinthifolius</italic> Raddi
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 15 days</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Wistar rats</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored increased immobility time in rats subjected to a model of neuropathic pain</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B46-molecules-22-01290" ref-type="bibr" class="xref">46</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (ketamine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Syzygium aromaticum</italic> (L.) Merr, &amp; L.M.Perry
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">50–200 mg/kg 
     <break class="break"/>(100 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both tests</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B47-molecules-22-01290" ref-type="bibr" class="xref">47</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine) LD
     <sub class="sub">50</sub> = 45564.556 g/kg (po)
    </td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Syzygium aromaticum</italic> (L.) Merr, &amp; L.M.Perry
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 5 weeks</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">50–200 mg/kg 
     <break class="break"/>(50 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, novelty-suppressed feeding behavior</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored sucrose preference in CUMS rats; 
     <break class="break"/>Reverted the increased latency to feed in a unfamiliar environment in CUMS rats
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored hippocampal BDNF protein, p-ERK and p-CREB expression</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B47-molecules-22-01290" ref-type="bibr" class="xref">47</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Thymus vulgaris</italic> L. (Lamiaceae)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse (female)</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(10 min)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B41-molecules-22-01290" ref-type="bibr" class="xref">41</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Toona ciliata</italic> Roem. var. 
     <italic class="italic">yunnanensis</italic> (C. DC.) C.Y. WU
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–80 mg/kg 
     <break class="break"/>(10 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both tests</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B48-molecules-22-01290" ref-type="bibr" class="xref">48</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Toona ciliata Roem</italic> var. yunnanensis (C. DC.) C.Y. WU
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–80 mg/kg 
     <break class="break"/>(10 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No behavioral effects were evaluated</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Increased hippocampal monoamines (5-HT, NE and DA) and BDNF contents in CUMS rats;</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">DR+
     <break class="break"/>Controls: negative and positive (imipramine)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B48-molecules-22-01290" ref-type="bibr" class="xref">48</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Reduced serum corticosterone in CUMS rats</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Valeriana wallichii</italic> DC.
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute and 14 days</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Albino Laca mouse (male and female)</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–40 mg/kg 
     <break class="break"/>(10 mg/kg)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Increased noradrenaline and 5-HT levels after repeated administration; The acute antidepressant effect was prevented by pretreatment with L-arginine (NO precursor) and sildenafil (phosphodiesterase 5 inhibitor), while it was potentiated with L-NAME (NOS inhibitor) and methylene blue (inhibitor of soluble guanylate cyclase)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B49-molecules-22-01290" ref-type="bibr" class="xref">49</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   </tr>
   <tr class="tr">
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
     <italic class="italic">Zingiber officinale</italic> Roscoe
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse (female)</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber 
     <break class="break"/>(10 min)
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[
     <xref rid="B41-molecules-22-01290" ref-type="bibr" class="xref">41</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot class="table-wrap-foot">
  <fn class="fn">
   <p class="p">FST: forced swimming test; TST: tail suspension test; OFT: open field test; CUMS: Chronic unpredictable mild stress; DR−: absence of dose/concentration response; DR+: dose/concentration response design; 5-HT: serotonin; DA: dopamine; NE: noradrenaline.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
